Effect of PEEP=5cmH2O vs PEEP=0cmH2O PSV Strategies During SBT on Successful Disconnection From Mechanical Ventilation (PPSDMV-RCT)

June 17, 2021 updated by: Liu ZiMeng, First Affiliated Hospital, Sun Yat-Sen University

Effect of PEEP=5cmH2O vs PEEP=0cmH2O PSV Strategies During SBT on Successful Disconnection From Mechanical Ventilation: A Randomized Clinical Trial

Mechanical ventilation is the most common means of life support in intensive care unit. Daily spontaneous breathing trial (SBT) is the most effective method to evaluate whether patients on mechanical ventilation can be removed from the ventilator, thus reducing mechanical ventilation duration and ventilator-related complications. Pressure support ventilation and T-piece ventilation are the two most commonly used SBT methods, lasting from 30 minutes to 2 hours. However, the parameter setting for SBT using PSV method has not been completely agreed, especially regarding the use of positive end-expiratory pressure (PEEP). Therefore, we intend to conduct a single-center, prospective, randomized, controlled study to evaluate the impact of PEEP=0cmH2O and PEEP=5cmH2O on extubation success rate and re-intubation rate in mechanically ventilated patients, to provide high-level clinical evidence on the use of PEEP for SBT in patients with mechanical ventilation, so as to reduce the duration of mechanical ventilation and complications related to mechanical ventilation.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Patients who met the withdrawal screening criteria were randomly divided into groups for self-breathing test by PSV method with low pressure support level. Parameters of each group were as follows. In the experimental group, PS = 8 cmH2O, PEEP= 5 cmH2O, and FiO2 level was consistent with that before SBT.The control group: PSV mode, PS = 8 cmH2O, PEEP=0 cmH2O, FiO2 level was consistent with that before SBT.The duration of the spontaneous breathing test was 30 minutes, and the results of the spontaneous breathing test were evaluated at the end of the test.Endotracheal intubation was removed if the patient was successfully assessed for spontaneous breathing. Record the date and time of extubation.Patients with endotracheal intubation were treated with nasal hyperflow oxygen therapy for respiratory support.Patients with SBT failure were reconnected to the ventilator, and mechanical ventilation was given according to the ventilation mode and parameters before the spontaneous breathing test.The reasons for SBT failure were recorded and these patients were not randomized to SBT.If respiratory failure occurs within 48 hours after extubation, the attending physician decides the respiratory treatment plan.These patients were also not included in the subsequent SBT randomization.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: ZiMeng Liu, Doctor
  • Phone Number: 020-87755766-8454
  • Email: sumslzm@163.com

Study Locations

    • Guangdong
      • Guanzhou, Guangdong, China, 510080
        • Recruiting
        • The first affiliated hospital of SunYatSen University
        • Contact:
          • Liu Zimeng, doctor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1) Older than 18;
  • 2) Patients with mechanical ventilation for 24h;
  • 3) Meet the screening standards for daily disconnection;
  • 4) The study complies with the Declaration of Helsinki and China's regulations on clinical trial research, and the patient or his/her family members have informed and agreed to participate in the study.

Exclusion Criteria:

  • 1) Patients undergoing tracheotomy;
  • 2) Patients who refuse to be intubated again after endotracheal intubation is removed;
  • 3) Patients on long-term mechanical ventilation: mechanical ventilation duration was continuous for 21 days, >6 h/d;
  • 4) The attending physician decides the withdrawal plan (e.g., the potential pathology is more favorable to the specific withdrawal plan).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PEEP=5cmH2O
In PSV mode,PS = 8 cmH2O,PEEP= 5 cmH2O, and FiO2 level was consistent with that before SBT
The patients who met the withdrawal screening criteria were randomly divided into low pressure support level PSV spontaneous respiration test.The duration of the spontaneous breathing test was 30 minutes, and the results of the spontaneous breathing test were evaluated at the end of the test.
Experimental: PEEP=0cmH2O
In PSV mode,PS = 8 cmH2O,PEEP=0 cmH2O, and FiO2 level was consistent with that before SBT
The patients who met the withdrawal screening criteria were randomly divided into low pressure support level PSV spontaneous respiration test.The duration of the spontaneous breathing test was 30 minutes, and the results of the spontaneous breathing test were evaluated at the end of the test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extubation success rate
Time Frame: during 48 hours after the first SBT
The success rate of extubation (during 48 hours after the first SBT if successfully removed from the ventilator).
during 48 hours after the first SBT
Reintubation rate
Time Frame: during 48 hours after extubation
The reintubation rate of respiratory failure after extubation.
during 48 hours after extubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reintubation rate at 72 hours
Time Frame: during 72 hours after extubation
Reintubation rate at 72 h
during 72 hours after extubation
No mechanical ventilation duration in ICU
Time Frame: From first transfer in ICU to transfer out ICU up to 28 days after randomization
No mechanical ventilation duration in ICU
From first transfer in ICU to transfer out ICU up to 28 days after randomization
Length of ICU stay
Time Frame: From admission to discharge from ICU up to 28 days after randomization
Length of ICU stay
From admission to discharge from ICU up to 28 days after randomization
ICU mortality, 28-day mortality
Time Frame: 28 day
ICU mortality, 28-day mortality
28 day
Results of blood gas analysis
Time Frame: every 30 min during SBT up one hour to and 30min after extubation
PaCO2 and PaO2 (SBT screening, SBT completion, 30min after extubation)
every 30 min during SBT up one hour to and 30min after extubation
Respiratory mechanical parameters
Time Frame: every 30 min during SBT up to one hour
lung compliance monitoring: Static and dynamic lung compliance
every 30 min during SBT up to one hour
Predictors of withdrawal of patients on mechanical ventilation
Time Frame: every 30 min during SBT up one hour and before extubation
airway occlusion pressure
every 30 min during SBT up one hour and before extubation
Predictors of withdrawal of patients on mechanical ventilation
Time Frame: every 30 min during SBT up one hour and before extubation
negativeinspiratory force
every 30 min during SBT up one hour and before extubation
Predictors of withdrawal of patients on mechanical ventilation
Time Frame: every 30 min during SBT up to one hour and before extubation
Rapid Shallow Breathing Index
every 30 min during SBT up to one hour and before extubation
Vital signs
Time Frame: every 15 min during SBT up to one hour and 30 min after extubation
Heart Rate
every 15 min during SBT up to one hour and 30 min after extubation
Vital signs
Time Frame: every 15 min during SBT up to one hour and 30 min after extubation
SpO2
every 15 min during SBT up to one hour and 30 min after extubation
Vital signs
Time Frame: every 15 min during SBT up to one hour and 30 min after extubation
Blood Pressure
every 15 min during SBT up to one hour and 30 min after extubation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest electrical impedance imaging (EIT)
Time Frame: from the start to the end of SBT up to one hour and 30min after extubation
region of interests(RI),Center of Ventilation(COV),end expiratory lung inmpedance(EELI), △EELi
from the start to the end of SBT up to one hour and 30min after extubation
Subjective score of patients with dyspnea
Time Frame: every 30 min during SBT up to one hour and 30min after extubation
Score 0-10: 0 for no dyspnea, 10 for severe dyspnea
every 30 min during SBT up to one hour and 30min after extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ZiMeng Liu, Doctor, First Affiliated Hospital, Sun Yat-Sen University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2020

Primary Completion (Anticipated)

August 1, 2021

Study Completion (Anticipated)

August 1, 2021

Study Registration Dates

First Submitted

June 7, 2020

First Submitted That Met QC Criteria

June 17, 2021

First Posted (Actual)

June 25, 2021

Study Record Updates

Last Update Posted (Actual)

June 25, 2021

Last Update Submitted That Met QC Criteria

June 17, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2020761001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe